Azathioprine in Behçet's syndrome. Effects on long‐term prognosis
Vedat Hamuryudan(Istanbul University), Hasan Yazıcı(Istanbul University), Yılmaz Özyazgan(Istanbul University-Cerrahpaşa), Nail Hizli(Istanbul University), Cem Mat(Access to Wholistic and Productive Living Institute), Mustafa Şlenocak(Istanbul University), Yalçın Tüzün(Istanbul University), Sebahattin Yurdakul(Istanbul University)
Cited by 280
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
The Long-Term Mortality and Morbidity of Behçet Syndrome
|Medicine|2003|757
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
A Controlled Trial of Azathioprine in Behçet's Syndrome
|New England Journal of Medicine|1990|646
Behçet syndrome: a contemporary view
|Nature Reviews Rheumatology|2018|438